Lipoic Acid Use and Functional Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke and Diabetes.
Kang-Ho ChoiMan-Seok ParkJoon-Tae KimHyung-Seok KimJa-Hae KimTai-Seung NamSeong-Min ChoiSeung-Han LeeByeong-Chae KimMyeong-Kyu KimKi-Hyun ChoPublished in: PloS one (2016)
The use of aLA in patients with AIS and diabetes who are treated with tPA is associated with favorable outcomes. These results indicate that aLA could be a useful intervention for the treatment of AIS after reperfusion therapy.
Keyphrases
- acute ischemic stroke
- type diabetes
- glycemic control
- cardiovascular disease
- randomized controlled trial
- acute myocardial infarction
- pulmonary embolism
- coronary artery disease
- insulin resistance
- replacement therapy
- bone marrow
- acute coronary syndrome
- blood brain barrier
- left ventricular
- weight loss
- smoking cessation